Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6980)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 7, 2022 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Suryadevara V, Roy A, Sahoo J, Kamalanathan S, Naik D, Mohan P, Kalayarasan R. Incretin based therapy and pancreatic cancer: Realising the reality. World J Gastroenterol 2022; 28(25): 2881-2889 [PMID: 35978867 DOI: 10.3748/wjg.v28.i25.2881] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v28/i25/2881.htm |
| Number | Citing Articles |
| 1 |
Estelle Grasset, François Briand, Nicolina Virgilio, Christiane Schön, Manfred Wilhelm, Benoit Cudennec, Rozenn Ravallec, Hairati Aboubacar, Sara Vleminckx, Janne Prawitt, Thierry Sulpice, Elien Gevaert. A Specific Collagen Hydrolysate Improves Postprandial Glucose Tolerance in Normoglycemic and Prediabetic Mice and in a First Proof of Concept Study in Healthy, Normoglycemic and Prediabetic Humans. Food Science & Nutrition 2024; doi: 10.1002/fsn3.4538
|
| 2 |
Carla Micaela Cuttica, Irene Maria Briata, Andrea DeCensi. Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment. Nutrients 2023; 15(17): 3737 doi: 10.3390/nu15173737
|
| 3 |
Jiaqi Wu, Liang Tang, Feng Zheng, Xun Chen, Lei Li. A review of the last decade: pancreatic cancer and type 2 diabetes. Archives of Physiology and Biochemistry 2023; : 1 doi: 10.1080/13813455.2023.2252204
|
| 4 |
Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Chela, Ebubekir Daglilar. The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study. Cancers 2024; 16(9): 1625 doi: 10.3390/cancers16091625
|